Skip to Content

Koselugo 25 mg hard capsules

Licence status
Authorised: 17/06/2021
Active substances
Selumetinib Sulfate
Dosage Form
Capsule, hard
Licence number
EU/1/21/1552/002
Licence holder
AstraZeneca AB

Licence information

ATC code
L01EE04 Selumetinib, L01XE Protein kinase inhibitors
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/06/2021